Quarterly ResultMay 1, 2026, 03:51 PM
OrthoPediatrics Q1 Revenue +13.3% to $59.36M; Net Loss $(10.69)M
AI Summary
OrthoPediatrics Corp. reported a 13.3% increase in net revenue for Q1 2026, reaching $59.36 million, with a net loss of $(10.69) million, comparable to the prior year. The company completed the acquisition of London Orthotic Consultancy Consolidated Ltd (LOC) for GBP 5.22 million cash and GBP 0.6 million in promissory notes, with potential earnouts. Additionally, OrthoPediatrics amended its Term Loan Agreement to establish a new $20 million delayed draw term loan facility.
Key Highlights
- Net revenue increased 13.3% to $59.36 million for Q1 2026 from $52.41 million in Q1 2025.
- Reported a net loss of $(10.69) million, or $(0.45) per share, for Q1 2026.
- Acquired London Orthotic Consultancy Consolidated Ltd (LOC) for GBP 5.22 million cash and GBP 0.6 million in promissory notes.
- Established a new $20 million delayed draw term loan facility, drawable until June 30, 2027.
- Goodwill increased by $5.92 million due to clinic acquisitions in Q1 2026.
- Cash, cash equivalents, and restricted cash decreased to $14.25 million at March 31, 2026, from $21.62 million at January 1, 2026.
- Operating loss improved to $(8.34) million in Q1 2026 from $(10.98) million in Q1 2025.